Moderna Says RSV Vaccine 84% Effective at Preventing Symptoms in Older Adults Moderna Says RSV Vaccine 84% Effective at Preventing Symptoms in Older Adults

Moderna said on Tuesday that its experimental mRNA vaccine for respiratory syncytial virus was 83.7% effective in a late-stage trial at preventing at least two symptoms, such as cough and fever, in adults aged 60 and older.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news